Alembic Pharmaceuticals Ltd
APLLTD
Company Profile
Business description
Alembic Pharmaceuticals Ltd is a specialty and generic drug manufacturing company. The company focuses on manufacturing and marketing generic pharmaceutical products across the globe. Alembic also operates a branded formulation business that covers a range of therapeutic areas such as dermatology, oncology, ophthalmology, and injectable formulations. The company considers merger and acquisition investment as a potential component of its operational growth strategy for expanding its research, development, manufacturing, and marketing capabilities.
Contact
Alembic Road
VadodaraGJ390 003
INDT: +91 2656637000
Sector
Healthcare
Stock type
Defensive
Industry
Drug Manufacturers - Specialty & Generic
Fiscal Year End
31 March 2025
Employees
14,858
Stocks News & Analysis
stocks
DeepSeek revelation hits US chip stocks, ASX data centres and uranium
Shockwaves from Monday's AI stock panic in the US were largely confined to two ASX industries.
video
What does a weak Aussie dollar mean for investors?
Morningstar Investment Management's Chief Investment Officer for Asia Pacific weighs in on the weak Aussie dollar and what this could mean for investors.
stocks
AI stock rout: The US selloff in 4 charts
Worries about Western AI dominance permeated the markets, with Nvidia stock plunging 17% alongside other chipmakers, utilities, and more.
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
|---|---|---|---|
| All Ordinaries | 8,755.50 | 54.80 | 0.63% |
| CAC 40 | 7,872.48 | 24.89 | -0.32% |
| DAX 40 | 21,637.53 | 206.95 | 0.97% |
| Dow JONES (US) | 44,713.52 | 136.83 | -0.31% |
| FTSE 100 | 8,557.81 | 23.94 | 0.28% |
| HKSE | 20,225.11 | 27.34 | 0.14% |
| NASDAQ | 19,632.32 | 101.26 | -0.51% |
| Nikkei 225 | 39,498.57 | 83.79 | 0.21% |
| NZX 50 Index | 12,933.60 | 69.44 | -0.53% |
| S&P 500 | 6,039.31 | 28.39 | -0.47% |
| S&P/ASX 200 | 8,502.70 | 55.70 | 0.66% |
| SSE Composite Index | 3,250.60 | 2.03 | -0.06% |